CVS Health (NYSE:CVS) Shares Gap Up – Should You Buy?

CVS Health Corporation (NYSE:CVS) shares gapped up before the market opened on Tuesday . The stock had previously closed at $73.28, but opened at $77.42. CVS Health shares last traded at $76.81, with a volume of 3,863,623 shares.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CMS finalized a 2.48% net increase to 2027 Medicare Advantage payments (adding roughly $13B industry-wide), which directly improves revenue and margin visibility for CVS’s large Aetna/MA business and underpins upside to future EPS. Medicare Finalizes 2.48% Rate Increase, Lifting Health Insurer Outlook
• Positive Sentiment: Market reaction: reports show insurer stocks, including CVS, jumped on the MA payment hike (one outlet noted a ~5% surge), reflecting investor re-rating of MA exposure. This short-term buying is boosting today’s share move. CVS Health (CVS) Shares Surge 5% on $13B Medicare Advantage Payment Increase
• Positive Sentiment: Analyst/idea coverage: a recent Seeking Alpha piece frames CVS as a diversified income play with improving Medicare Advantage rate visibility for 2027, supporting the longer-term investment thesis. CVS Health: A Diversified Income Play With Improving MA Rate Visibility For 2027
• Positive Sentiment: Retail innovation: CVS is rolling out apothecary-style pharmacy stores—an execution step to differentiate the retail experience and potentially boost same-store sales and pharmacy margins over time. CVS Health launches apothecary-style pharmacy stores
• Neutral Sentiment: Aetna provider survey: findings show provider optimism and opportunities to simplify care and deepen payer-provider trust, but administrative burden remains a top challenge—positive long-term signal but mixed near-term impact. Aetna Provider Survey Reveals Optimism and Opportunities to Simplify Health Care
• Negative Sentiment: Macro/headline risk: equity futures were pressured by geopolitical concerns (Iran-related headlines), which could cap broader market gains and weigh on CVS despite sector-specific positives. Equity Futures Fall as Trump’s Latest Iran Deadline Looms

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on CVS shares. Leerink Partners restated an “outperform” rating and set a $98.00 price objective on shares of CVS Health in a research report on Thursday, March 5th. JPMorgan Chase & Co. raised their price objective on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. The Goldman Sachs Group raised their price objective on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Bank of America lowered their price objective on CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Finally, Barclays raised their price objective on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $94.95.

CVS Health Stock Performance

The firm has a market capitalization of $100.27 billion, a P/E ratio of 57.11, a P/E/G ratio of 0.77 and a beta of 0.51. The stock has a fifty day simple moving average of $75.73 and a two-hundred day simple moving average of $77.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last issued its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date is Thursday, April 23rd. CVS Health’s payout ratio is presently 192.75%.

Institutional Investors Weigh In On CVS Health

Hedge funds have recently added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $1,666,265,000. Wellington Management Group LLP increased its holdings in shares of CVS Health by 193.2% during the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after acquiring an additional 12,233,675 shares in the last quarter. Amundi increased its holdings in shares of CVS Health by 95.3% during the third quarter. Amundi now owns 7,453,980 shares of the pharmacy operator’s stock valued at $572,665,000 after acquiring an additional 3,637,943 shares in the last quarter. Capital Research Global Investors increased its holdings in shares of CVS Health by 24.5% during the third quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator’s stock valued at $864,667,000 after acquiring an additional 2,253,531 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of CVS Health by 70.5% during the third quarter. Arrowstreet Capital Limited Partnership now owns 5,294,134 shares of the pharmacy operator’s stock valued at $399,125,000 after acquiring an additional 2,188,307 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.